Sunopta, Inc’s recently made public that its Officer CHAD M HAGEN acquired Company’s shares for reported $0.25 million on Feb 27 ’25. In the deal valued at $6.20 per share,39,527 shares were bought.
Then, CHAD M HAGEN bought 209,475 shares, generating $1,618,362 in total proceeds.
Before that, Fisher Rebecca sold 13,142 shares. Sunopta, Inc shares valued at $99,644 were divested by the Director at a price of $7.58 per share. As a result of the transaction, Fisher Rebecca now holds 108,500 shares, worth roughly $0.64 million.
DA Davidson initiated its Sunopta, Inc [STKL] rating to a Buy in a research note published on December 08, 2023; the price target was $8. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Stephens began covering STKL with “an Overweight” recommendation on June 23, 2023. Cowen started covering the stock on September 10, 2021. It rated STKL as “an Outperform”.
Price Performance Review of STKL
On Monday, Sunopta, Inc [NASDAQ:STKL] saw its stock fall -6.22% to $5.88. Over the last five days, the stock has lost -18.78%. Sunopta, Inc shares have fallen nearly -23.64% since the year began. Nevertheless, the stocks have fallen -2.16% over the past one year. While a 52-week high of $8.11 was reached on 01/02/25, a 52-week low of $4.88 was recorded on 03/03/25. SMA at 50 days reached $7.37, while 200 days put it at $6.49.
Levels Of Support And Resistance For STKL Stock
The 24-hour chart illustrates a support level at 5.72, which if violated will result in even more drops to 5.57. On the upside, there is a resistance level at 6.17. A further resistance level may holdings at 6.47. The Relative Strength Index (RSI) on the 14-day chart is 24.90, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.90%. Stochastics %K at 12.39% indicates the stock is a buying.
The most recent change occurred on July 09, 2021 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $15 price target.